The Sunshine Biopharma (OTC: SBFM) stock may have fallen sharply not too long ago but it seems that the stock is now in recovery mode and that was apparent in its price action on Tuesday.
Yesterday, the stock recovered strongly and went up by as high as 11% as investors flocked to it again. That being said, it is also necessary to point out that there was no news with regards to Sunshine that could have resulted in such a rally.
The last major news with regards to the company was on March 4 when Sunshine announced that it accepted a shipment of Adva-27a from its Chinese manufacturer. The shipment was then sent to the company to the laboratories owned by the company’s drug development partner in Canada. It was a significant development, however, it might not have had a link with the latest gains made by the stock. It might be a good idea for investors at this point to keep an eye on the stock.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.